United States· US:59137-365_2d06b03c-17aa-0492-e063-6294a90abd8f
GRAFAPEX
A treosulfan product containing treosulfan, registered in United States by Medexus Pharma, Inc.. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Treosulfan is registered in 16 of 19 countries.
Countries holding a registration under ATC L01AB02 (treosulfan), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Treosulfan · ATC L01AB02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TREOSULFAN
- Manufacturer
- Medexus Pharma, Inc.
- Country
- United States (US)
- ATC code
- L01AB02
- ATC class
- Treosulfan
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1159137365011 VIAL in 1 CARTON (59137-365-01) / 5 g in 1 VIAL
- ndc1159137-365-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Treosulfan in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTRECONDIMedac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
- United KingdomTrecondi 1g powder for solution for infusionmedac UK
- BelgiumTrecondi 1 gMedac
- FinlandTrecondiMedac Gesellschaft Für Klinische Spezialpräparate mbH
- NetherlandsTrecondi 1 g poeder voor oplossing voor infusieMedac Gesellschaft für klinische Spezialpräparate mbH
- PolandTrecondimedac Gesellschaft fuer klinische Spezialpraeparate mbH
- SwedenTrecondi 1 g Pulver till infusionsvätska, lösningmedac Gesellschaft für klinische Spezialpräparate mbH
- FranceTRECONDI 1 g, poudre pour solution pour perfusionMEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE (ALLEMAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Treosulfan Tillomed
- Belgium · Treosulfan Tillomed
- Czechia · Treosulfan Tillomed
- Germany · Ovastat, Treosulfan Tillomed
- Denmark · Treosulfan Tillomed
- Spain · Treosulfano Zentiva
- Finland · Treosulfan Tillomed
- France · Treosulfan Tillomed
- United Kingdom (Northern Ireland) · Treosulfan Tillomed Laboratories
- Greece · Treosulfan Tillomed
- Ireland · Treosulfan Tillomed
- Iceland · Trecondi
- Liechtenstein · Trecondi
- Netherlands · Treosulfan Tillomed
- Norway · Trecondi, Treosulfan Tillomed
- Poland · Treosulfan Zentiva
- Portugal · Treossulfano Tillomed
- Romania · Treosulfan Tillomed
- Sweden · Treosulfan Tillomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f59e4b13-d387-4f78-bef0-95c99b63fad6 GET /v1/drugs/f59e4b13-d387-4f78-bef0-95c99b63fad6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "5000",
"substance": "TREOSULFAN",
"productndc": "59137-365",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/5g",
"application_number": "NDA214759",
"marketing_category": "NDA"
}See everything about treosulfan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.